Clinical Trials

Tightly controlled trials are poor predictors of real-world outcomes

With illegal drug use rising, can a cancer drug be repurposed to cure cocaine addiction?

Not all successful biosimilar applications in Europe follow guidelines to the letter

In this article, triple detection SEC and MDRS are considered within the context of characterizing complex drug formulations, with specific case studies and results illustrating their application.

This article explains how dynamic light scattering (DLS) can be used to gather particle size distribution data for the successful use of nanosized colloidal gold in drug delivery applications.

Nominations for the 2017 Power List are now open and will close on February 1, 2017.

Sitting Down With... Ibraheem “Ibs” Mahmood, President and Chief Executive Officer, DrugDev, founded in the UK and headquartered in King of Prussia, PA, USA.

How difficult is it to develop a new drug? Statistics have the answer

The EMA says it will review its standards for first-in-human trials

Cell therapy successes are widely hailed as breakthroughs, but will adverse effects and patient deaths hold the field back?